보리코나졸 점안이 배양 양성 진균각막염 치료에 미치는 임상 효과의 분석

다국어 초록 (Multilingual Abstract)

Purpose: To evaluate the efficacy of topical voriconazole in treatment of culture-positive fungal keratitis. Methods: Twenty-two cases of culture-positive fungal keratitis treated with topical anti-fungal drugs from October 2004 to December 2010 were evaluated and medical records were reviewed. Patients were divided into 3 groups according to the method of topical antifungal treatment; the first group (V, n = 6) received voriconazole monotherapy, the second group (V+, n = 10) received topical voriconazole and amphotericin B combined therapy, and the third group (A, n = 6) received amphotericin B monotherapy. Results: The treatment success rate between the 3 groups was not significantly different. The epithelial defect healing time of group V was shorter than group V+. Treatment failure risk factors included Fusarium spp. infection and the presence of hypopyon. Eight eyes received topical voriconazole maintenance therapy for 66 days and there were no corneal erosions or epithelial defects. Conclusions: In fungal keratitis, topical voriconazole is as effective as other standard treatments and provides a faster healing time in the corneal epithelium than other standard treatments. However, voriconazole should be used with caution and therapeutic surgery should be considered in Fusarium spp. infections. J Korean Ophthalmol Soc 2012;53(8):1068-1075

참고문헌 (Reference)

1 서제현, "진균 감염 시 전방 내 암포테리신 주입 치료 성적에 관련된 위험 인자 분석" 대한안과학회 48 (48): 1201-1211, 2007

2 김경훈, "보리코나졸로 치료한 진균안감염" 대한안과학회 49 (49): 1054-1060, 2008

3 Hariprasad SM, "Voriconazole in the treatment of fungal eye infections: a review of current literature" 92 : 871-878, 2008

4 이상준, "Topical and Oral Voriconazolein the Treatment of Fungal Keratitis" 대한안과학회 23 (23): 46-48, 2009

5 Al-Badriyeh D, "Stability of extemporaneously prepared voriconazole ophthalmic solution" 66 : 1478-1483, 2009

6 Gupta S, "Role of voriconazole in combined acanthamoeba and fungal corneal ulcer" 34 : 287-289, 2011

7 Baldinger J, "Retinal toxicity of amphotericin B in vitrectomised versus non-vitrectomised eyes" 70 : 657-661, 1986

8 Dupuis A, "Preparation and stability of voriconazole eye drop solution" 53 : 798-799, 2009

9 Lau D, "Penetration of voriconazole,1%, eyedrops into human aqueous humor: a prospective open-labelstudy" 126 : 343-346, 2008

10 Kernt M, "Intracameral voriconazole: in vitro safety for human ocular cells" 258 : 84-93, 2009

11 Shen YC, "Intracameral voriconazole injection in the treatment of fungal endophthalmitis resulting from keratitis" 149 : 916-921, 2010

12 Marangon FB, "In vitro investigation of voriconazole susceptibility for keratitis and endophthalmitis fungal pathogens" 137 : 820-825, 2004

13 Szabo Z, "In vitro efficacy of amphotericin B, 5-fluorocytosine, fluconazole, voriconazole and posaconazole against Candida dubliniensis isolates using time-k2ill methodology" 53 : 196-199, 2010

14 Lin CP, "Effect of fortified antibiotic solutions on corneal epithelial wound healing" 19 : 204-206, 2000

15 Hariprasad SM, "Determination of vitreous, aqueous, and plasma concentration of orally administered voriconazole in humans" 122 : 42-47, 2004

16 Chang CH, "Cytotoxicity of intracameral injection drugs to corneal endothelium as evaluated by corneal endothelial cell culture" 14 : 71-76, 1995

17 Han SB, "Cytotoxicity of Voriconazole on Cultured Human Corneal Endothelial Cells" AMER SOC MICROBIOLOGY 55 (55): 4519-4523, 2011

18 O'Day DM, "Corneal penetration of topical amphotericin B and natamycin" 5 : 877-882, 1986

19 Al-Badriyeh D, "Clinical utility of voriconazole eye drops in ophthalmic fungal keratitis" 4 : 391-405, 2010

20 Vemulakonda GA, "Aqueous and vitreous concentrations following topical administration of 1% voriconazole in humans" 126 : 18-22, 2008